GlassScriptPhysician profile
Kevin O Babb
NPI 1780729558
$1,466.27
in general payments reported to CMS, 2019-2025
9 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2022: $396 · 2023: $513 · 2024: $268 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $274.56 | 2022-2023 | Hyperrab |
| Inari Medical, INC. | $268.43 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $264.20 | 2023-2025 | Andexxa, Fasenra, Airsupra |
| Janssen Pharmaceuticals, INC | $228.60 | 2022-2023 | Xarelto |
| Abbott Laboratories | $136.30 | 2022 | |
| Pfizer INC. | $125.00 | 2019 | |
| Abbvie INC. | $116.72 | 2023 | |
| Mindray Ds USA, INC. | $34.92 | 2023 | Te X, Te7 Max |
| Vapotherm INC | $17.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Babb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.